Real-time enrollment status for this prostatic neoplasms clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:07 PM UTC
| NCT Number | NCT07285057 |
| Recruiting Status | Recruiting |
| Condition | Prostatic Neoplasms |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | February 23, 2026 (Feb 23, 2026) |
As of July 16, 2026: Clinical trial NCT07285057 is currently recruiting participants. This phase2 study for prostatic neoplasms is actively seeking new participants at 1 location across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07285057 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07285057 was last updated Feb 23, 2026 (February 23, 2026). HelloStudys verifies this status automatically.